Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02797600 · ClinicalTrials.gov registry record
Community Awareness, Resources and Education (CARE II) Project: Project 1
A clinical trial, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- 285
- Enrollment target
NCT02797600 is a clinical trial that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 285 participants.
The verdict
NCT02797600 has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 285 participants
- Enrollment target
Study Summary
The study hypothesis is that the increased incidence of cervical cancer observed in Appalachian women over their non-Appalachian counterparts is due in part to inherited and somatic alterations of key components of the Transforming Growth Factor β (TGFβ) signaling pathway.
Interventions
- BEHAVIORAL Questionnaires
- OTHER Biological Samples
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 285 participants |
| Start Date | 2011-06 |
| Est. Completion | 2015-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02797600
The ClinicalTrials.gov registry entry for NCT02797600 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 285 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Questionnaires is the first listed.
NCT02797600 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02797600 about?
NCT02797600 is a clinical study titled "Community Awareness, Resources and Education (CARE II) Project: Project 1". The study hypothesis is that the increased incidence of cervical cancer observed in Appalachian women over their non-Appalachian counterparts is due in part to inherited and somatic alterations of key components of the Transforming Growth Factor β (TGFβ) signaling pathway.
What is the current status of trial NCT02797600?
This trial is currently completed. The enrollment target is 285 participants. The study started on 2011-06. Estimated completion is 2015-04.
What interventions are being tested in trial NCT02797600?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Biological Samples (OTHER).
Who is sponsoring clinical trial NCT02797600?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.